Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Kaslow

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Chemical Immunology|June 13, 2002
Transmission-blocking vaccinesDavid C Kaslow
NPJ Vaccines|April 13, 2021
Force of infection: a determinant of vaccine efficacy?David C Kaslow
NPJ Vaccines|December 10, 2020
Malaria vaccine research & innovation: the intersection of IA2030 and zero malariaDavid C Kaslow
NPJ Vaccines|June 9, 2020
Certainty of success: three critical parameters in coronavirus vaccine developmentDavid C Kaslow
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Efforts to Develop Pfs25 VaccinesDavid C Kaslow
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 4, 2004
A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseasesDavid C Kaslow
Human Vaccines|January 6, 2007
Biological feasibility of developing prophylactic vaccines for viral pathogens: incubation period as a critical parameterDavid C Kaslow
Vaccine|October 4, 2015
RTS,S: Toward a first landmark on the Malaria Vaccine Technology RoadmapDavid C Kaslow, Sophie Biernaux
Annual Review of Medicine|August 17, 2010
Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine developmentDavid C Kaslow, John W Shiver
JAMA|June 5, 2025
Pausing Chikungunya Vaccination and Accelerated ApprovalVinay Prasad, David C Kaslow, Sixun Yang
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Chemical Immunology|June 13, 2002
Transmission-blocking vaccinesDavid C Kaslow
NPJ Vaccines|April 13, 2021
Force of infection: a determinant of vaccine efficacy?David C Kaslow
NPJ Vaccines|December 10, 2020
Malaria vaccine research & innovation: the intersection of IA2030 and zero malariaDavid C Kaslow
NPJ Vaccines|June 9, 2020
Certainty of success: three critical parameters in coronavirus vaccine developmentDavid C Kaslow
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Efforts to Develop Pfs25 VaccinesDavid C Kaslow
Transactions of the Royal Society of Tropical Medicine and Hygiene|August 4, 2004
A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseasesDavid C Kaslow
Human Vaccines|January 6, 2007
Biological feasibility of developing prophylactic vaccines for viral pathogens: incubation period as a critical parameterDavid C Kaslow
Vaccine|October 4, 2015
RTS,S: Toward a first landmark on the Malaria Vaccine Technology RoadmapDavid C Kaslow, Sophie Biernaux
Annual Review of Medicine|August 17, 2010
Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine developmentDavid C Kaslow, John W Shiver
JAMA|June 5, 2025
Pausing Chikungunya Vaccination and Accelerated ApprovalVinay Prasad, David C Kaslow, Sixun Yang
Pageof 9